A multicenter phase II trial of tumor treating fields plus chemotherapy for first-line treatment of gastric adenocarcinoma

被引：0
|
作者：
Li, Jin
Yeo, Winnie
Lam, Ka-On
机构：
[1] Fudan Univ, Shanghai Med Coll, Dept Oncol, Dept Med Oncol,Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Shenzhen Hosp, Shenzhen, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS474
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy
    Luebbert, Michael
    Rueter, Bjoern H.
    Claus, Rainer
    Schmoor, Claudia
    Schmid, Mathias
    Germing, Ulrich
    Kuendgen, Andrea
    Rethwisch, Volker
    Ganser, Arnold
    Platzbecker, Uwe
    Galm, Oliver
    Brugger, Wolfram
    Heil, Gerhard
    Hackanson, Bjoern
    Deschler, Barbara
    Doehner, Konstanze
    Hagemeijer, Anne
    Wijermans, Pierre W.
    Doehner, Hartmut
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03): : 393 - 401
  • [42] Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma:: Final report of a phase II trial
    Simon, George R.
    Verschraegen, Claire F.
    Jaenne, Pasi A.
    Langer, Corey J.
    Dowlati, Afshin
    Gadgeel, Shirish M.
    Kelly, Karen
    Kalemkerian, Gregory P.
    Traynor, Anne M.
    Peng, Guangbin
    Gill, John
    Obasaju, Coleman K.
    Kindler, Hedy L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3567 - 3572
  • [43] Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer
    Liu, Chaoying
    Sun, Qing
    Hang, Xiaosheng
    Zhong, Baoliang
    Wang, Daoyuan
    ANTI-CANCER DRUGS, 2008, 19 (08) : 825 - 831
  • [44] A randomized phase II trial of docetaxel plus S-1 versus docetaxel plus cisplatin in advanced gastric cancer as a first-line treatment
    Jeung, H.
    Im, C.
    Rha, S.
    Ahn, J.
    Shin, S.
    Noh, S.
    Roh, J.
    Chung, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [45] A Multicenter, Randomized, Phase 3 Trial of Penpulimab in Combination With Anlotinib or Chemotherapy as First-Line Treatment in Advanced NSCLC
    Han, B.
    Chen, J.
    Xie, Q.
    Yao, W.
    Shi, H.
    Zhao, Y.
    Song, W.
    Jin, X.
    Wang, Z.
    Li, B.
    Xia, Y.
    Jiao, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S650 - S650
  • [46] Phase II trial of gemcitabine and cisplatin plus ipilimumab as first-line treatment for metastatic urothelial carcinoma
    Gartrell, Benjamin Adam
    Hahn, Noah M.
    Hutson, Thomas E.
    Sonpavde, Guru
    Hauke, Ralph J.
    Starodub, Alexander
    Small, Alexander C.
    Tsao, Che-Kai
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Multicenter phase II study of oral capecitabine plus irinotecan as first-line chemotherapy in advanced colorectal cancer: A Korean Cancer Study Group Trial
    Kim, TW
    Kang, WK
    Chang, HM
    Park, JO
    Ryoo, BY
    Ahn, JS
    Zang, DY
    Lee, KH
    Kang, YK
    Kim, SR
    Kim, HK
    ACTA ONCOLOGICA, 2005, 44 (03) : 230 - 235
  • [48] RATIONALE 305: Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line therapy in patients with gastric or gastroesophageal junction adenocarcinoma
    Xu, R.
    Arkenau, T.
    Bang, Y.
    Denlinger, C.
    Kato, K.
    Tabernero, J.
    Wang, J.
    Li, J.
    Castro, H.
    Moehler, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S97 - S98
  • [49] STELLAR: Final results of a phase II trial of TTFields with chemotherapy for first-line treatment of pleural mesothelioma
    Grosso, F.
    Aerts, J. G.
    Madrzak, J.
    Dziadziuszko, R.
    Ramlau, R.
    Cedres, S.
    Hiddinga, B.
    van Meerbeeck, J. P.
    Mencoboni, M.
    Planchard, D.
    Chella, A.
    Crino, L.
    Krzakowski, M. J.
    Ceresoli, G. L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [50] Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma A Phase 2 Clinical Trial
    Edeline, Julien
    Touchefeu, Yann
    Guiu, Boris
    Farge, Olivier
    Tougeron, David
    Baumgaertner, Isabelle
    Ayav, Ahmet
    Campillo-Gimenez, Boris
    Beuzit, Luc
    Pracht, Marc
    Lievre, Astrid
    Le Sourd, Samuel
    Boudjema, Karim
    Rolland, Yan
    Boucher, Eveline
    Garin, Etienne
    JAMA ONCOLOGY, 2020, 6 (01) : 51 - 59
12345